In contrast, in a Spanish study of incident HD patients, the mortality risk was lower in patients with Hb level > 13 g/dL compared to patients with a reference Hb level of 11–12 g/dL, regardless of ESA dose. Here, GSTM1 is linked to Huntington disease.